The Effect of Dexmedetomidine on the Renal Functions in Septic Critically Ill Patients

PHASE4RecruitingINTERVENTIONAL
Enrollment

128

Participants

Timeline

Start Date

October 1, 2024

Primary Completion Date

October 31, 2026

Study Completion Date

October 31, 2026

Conditions
SepsisSeptic ShockAcute Kidney Injury
Interventions
DRUG

Dexmedetomidine

Dexmedetomidine will be administered with an initial dose of 0.2 μg/kg/hour, infusion rate is to be titrated based on response for at least 24 hours.

DRUG

Propofol

Propofol will be administered as the comparator sedative with the standard treatment of sepsis and septic shock.

Trial Locations (1)

Unknown

RECRUITING

Cairo University, Cairo

All Listed Sponsors
lead

Cairo University

OTHER